Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Krystal Biotech (KRYS) Revenue (2021 - 2025)

Historic Revenue for Krystal Biotech (KRYS) over the last 4 years, with Q4 2025 value amounting to $107.1 million.

  • Krystal Biotech's Revenue rose 1754.93% to $107.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $389.1 million, marking a year-over-year increase of 3393.18%. This contributed to the annual value of $389.1 million for FY2025, which is 3394.49% up from last year.
  • Latest data reveals that Krystal Biotech reported Revenue of $107.1 million as of Q4 2025, which was up 1754.93% from $97.8 million recorded in Q3 2025.
  • Over the past 5 years, Krystal Biotech's Revenue peaked at $107.1 million during Q4 2025, and registered a low of -$1.5 million during Q1 2021.
  • Its 4-year average for Revenue is $66.3 million, with a median of $83.8 million in 2024.
  • Per our database at Business Quant, Krystal Biotech's Revenue surged by 87990.88% in 2024 and then surged by 1664.94% in 2025.
  • Quarter analysis of 4 years shows Krystal Biotech's Revenue stood at -$1.5 million in 2021, then soared by 2924.66% to $42.1 million in 2023, then skyrocketed by 116.2% to $91.1 million in 2024, then rose by 17.55% to $107.1 million in 2025.
  • Its Revenue stands at $107.1 million for Q4 2025, versus $97.8 million for Q3 2025 and $96.0 million for Q2 2025.